Neptune Wellness Nutraceutical Brand, Biodroga, Announces Accounts Receivable Factoring Facility of Up to $8 Million

Rhea-AI Summary

Neptune Wellness Solutions Inc. (NEPT) announced that its subsidiary, Biodroga Nutraceuticals Inc., has entered into an accounts receivable factoring facility and inventory finance rider with Alterna Capital Solutions, LLC. The Facility provides up to $3 million, with an option to increase to $8 million, at a Funds Usage Fee of prime plus 1% and a minimum interest rate of 9.5% per annum. Neptune provided a commercial guaranty, and the agreement will be in effect for 12 months, effective November 8, 2023.

LAVAL, QC, Nov. 29, 2023 /PRNewswire/ - Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NASDAQ: NEPT), a consumer-packaged goods company focused on plant-based, sustainable and purpose-driven lifestyle brands, today announced that its nutraceuticals brand subsidiary, Biodroga Nutraceuticals Inc. ("Biodroga"), has entered into an accounts receivable factoring facility and inventory finance rider (collectively, the "Facility") with Alterna Capital Solutions, LLC ("Alterna"). The amount available under the Facility at any given time is $3 million, which may be increased in $1 million increments up to a maximum of $8 million.

The terms of the Facility include a Funds Usage Fee of prime plus 1% with a minimum interest rate of 9.5% per annum. Alterna was granted a security interest in Biodroga's accounts receivable and inventory.

The agreement will remain in effect for a 12-month period, effective November 8, 2023, and will be automatically renewed. Neptune provided a commercial guaranty in connection with the Facility.

About Biodroga Nutraceuticals Inc.
Biodroga provides product development and turnkey solutions to its customers throughout North America. Biodroga offers a full range of services, whether it is leveraging our global network of suppliers to find the best ingredients or developing unique formulations that set our customers apart from their competition. Biodroga's core products are MaxSimil, various Omega-3 fish oils and other nutritional products, as well as softgel solutions. To learn more, please visit www.biodrogasolutions.com.

About Neptune Wellness Solutions Inc.
Neptune is a consumer-packaged goods company that aims to innovate health and wellness products. Founded in 1998 and headquartered in Laval, Quebec with a United States headquarters in Jupiter, Florida, the company focuses on developing a portfolio of high-quality, affordable consumer products that align with the latest market trends for natural, sustainable, plant-based and purpose-driven lifestyle brands. The Company's products are available in more than 29,000 retail locations and include well-known organic food and beverage brands such as Sprout Organics, Nosh, and Nurturme, as well as nutraceuticals brands like Biodroga and Forest Remedies. With its efficient and adaptable manufacturing and supply chain infrastructure, the company can quickly respond to consumer demand, and introduce new products through retail partners and e-commerce channels. Please visit neptunewellness.com for more details.

Disclaimer – Safe Harbor Forward–Looking Statements

Statements in this news release that are not statements of historical or current fact constitute "forward-looking statements" within the meaning of applicable securities laws. Such forward-looking statements involve known and unknown risks, uncertainties, and other unknown factors that could cause the actual results of Neptune to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements which explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms "believes", "belief", "expects", "intends", "projects", "anticipates", "will", "should" or "plans" to be uncertain and forward-looking. Forward-looking statements relate to future events or future performance and reflect management's expectations or beliefs regarding future events including, but not limited to, statements with respect to: the timing and outcome of the transactions described in this news release (collectively, the "Transaction"); the anticipated benefits of the Transaction to the parties; and the impact of the Transaction on the Company. In respect of the forward-looking statements and information concerning the anticipated benefits and completion of the Transaction and the anticipated timing for completion of the Transaction, the Company has provided such statements and information in reliance on certain assumptions that it believes are reasonable at this time. Although the Company believes that the assumptions and factors used in preparing the forward-looking information or forward-looking statements in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking statements and information included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking information or forward-looking information to reflect new information, subsequent events or otherwise unless required by applicable securities laws.

Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this news release. The forward-looking statements contained in this news release are expressly qualified in their entirety by this cautionary statement and the "Cautionary Note Regarding Forward-Looking Information" section contained in Neptune's latest Annual Information Form, which also forms part of Neptune's latest annual report on Form 40-F, and which is available on SEDAR at www.sedar.com, on EDGAR at www.sec.gov/edgar.shtml. All forward-looking statements in this news release are made as of the date of this news release. Neptune does not undertake to update any such forward-looking statements whether as a result of new information, future events or otherwise, except as required by law.

View original content to download multimedia:https://www.prnewswire.com/news-releases/neptune-wellness-nutraceutical-brand-biodroga-announces-accounts-receivable-factoring-facility-of-up-to-8-million-301999495.html

SOURCE Neptune Wellness Solutions Inc.

FAQ

What did Neptune Wellness Solutions Inc. (NEPT) announce?

Neptune announced that its subsidiary, Biodroga Nutraceuticals Inc., has entered into an accounts receivable factoring facility and inventory finance rider with Alterna Capital Solutions, LLC.

What is the amount available under the Facility?

The Facility provides up to $3 million, with an option to increase to $8 million.

What are the terms of the Facility?

The terms include a Funds Usage Fee of prime plus 1% and a minimum interest rate of 9.5% per annum.

When will the agreement be in effect?

The agreement will be in effect for 12 months, effective November 8, 2023.

What did Neptune provide in connection with the Facility?

Neptune provided a commercial guaranty in connection with the Facility.